Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Bicyclic imidazolyl derivatives as phosphodiesterase inhibitors, pharmaceutical compositions and method of use

Bicyclic imidazolyl derivatives as phosphodiesterase inhibitors, pharmaceutical compositions and method of use

US Patent 6130333 · Granted Oct 10, 2000

Estimated economic value: $225,695,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Bicyclic-fused heteroaryl or aryl compounds2025
Bicyclic-fused heteroaryl or aryl compounds2023
Bicyclic-fused heteroaryl or aryl compounds2020
Bicyclic-fused heteroaryl or aryl compounds2019
Bicyclic-fused heteroaryl or aryl compounds2018
P-cadherin antibodies2015
Pyrrolo[2,3-D]pyrimidine compounds2014
Pyrrolo[2,3-D]pyrimidine compounds2013
P-cadherin antibodies2011
P-cadherin antibodies2008
Substituted polycyclic aryl and heteroarpyl pyrazinones useful for selective inh2006
Substituted 5-membered polycyclic compounds useful for selective inhibition of t2006